case study

Multi-Stakeholder Co-Creation on Real-World Evidence

A client wishes to submit an HTA dossier to a payer institution for a therapeutic indication with many other approved treatments.

Situation

A client wishes to submit an HTA dossier to a payer institution for a therapeutic indication with many other approved treatments already existing on the market. The client did not previously consult patients or patient organizations in the development of the Patient Reported Outcomes data and is unsure how to approach it. The patient relevance of the data has been questioned and is not well justified by the company.

Our Solution

  • Identification of best partners among KOLs, allied health professionals and patient experts
  • Co-creation session prepared and moderated by admedicum
  • Full-day session jointly with the internal team 
  • Challenging status quo and identifying the need-gap
  • Brainstorming opportunities for further clinical and health economic evidence
  • Conceptualizing a plan for additional QoL/PROMs data
  • points acceptable to the company

Results

HTA relevant Real-World Evidence (RWE) ideas as a basis for internal decision making in future data collection